当前位置:主页 > 医学论文 > 药学论文 >

我国药品安全社会共治体系建设的困境及其治理

发布时间:2018-09-03 12:46
【摘要】:药品安全治理涉及社会生活中多元主体和多重利益关系,单纯依靠市场机制或是单方面政府管制无法从根本上解决问题。管理学中的多中心治理理论和经济法中的三元主体理论,为实现药品安全社会共治提供了理论基础。基于现有政府单一监管体系,我国药品市场存在市场失灵、政府失灵、社会失灵等诸多问题。为此,构建一个多元主体良性互动、理性制衡、有序参与、有力监督的社会共治体系尤为重要。解决的基本思路是:从企业、政府、社会三个维度出发,加强企业自律体系建设,完善政府监管体系,推进社会参与体系建设,以实现药品安全共治共享。
[Abstract]:Drug safety governance involves multiple subjects and multiple interests in social life. Simply relying on market mechanism or unilateral government regulation can not solve the problem fundamentally. The multi-center governance theory in management and the ternary subject theory in economic law provide a theoretical basis for the realization of drug safety social co-governance. Based on the single government supervision system, there are many problems in Chinese drug market, such as market failure, government failure, social failure and so on. Therefore, it is very important to construct a system of social co-governance with rational checks and balances, orderly participation and strong supervision. The basic thinking of the solution is: from the three dimensions of enterprise, government and society, we should strengthen the construction of self-discipline system of enterprises, perfect the system of government supervision and promote the construction of social participation system, so as to realize the sharing of drug safety.
【作者单位】: 重庆大学法学院;
【基金】:国家社会科学基金项目“公共规制的社会可接受性及实现路径研究”(13CFX009),项目负责人:靳文辉
【分类号】:R95


本文编号:2220017

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2220017.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户00fdd***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com